These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 17019537)

  • 21. Chronic erythropoietin treatment decreases post-infarct myocardial damage in rats without venous thrombogenic effect.
    Prunier F; Pottier P; Clairand R; Mercier A; Hajjar RJ; Planchon B; Furber A
    Cardiology; 2009; 112(2):129-34. PubMed ID: 18596374
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Spironolactone modulates expressions of cardiac mineralocorticoid receptor and 11beta-hydroxysteroid dehydrogenase 2 and prevents ventricular remodeling in post-infarct rat hearts.
    Takeda M; Tatsumi T; Matsunaga S; Hayashi H; Kimata M; Honsho S; Nishikawa S; Mano A; Shiraishi J; Yamada H; Takahashi T; Matoba S; Kobara M; Matsubara H
    Hypertens Res; 2007 May; 30(5):427-37. PubMed ID: 17587755
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Effects of perindopril on left ventricular remodeling and myocardial osteopontin expression in rats with myocardial infarction].
    Zhang YL; Zhou SX; Wang MH; Wang JF
    Nan Fang Yi Ke Da Xue Xue Bao; 2006 Nov; 26(11):1584-8. PubMed ID: 17121705
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antiplatelet therapy mitigates cardiac remodeling and dysfunction in congestive heart failure due to myocardial infarction.
    Sanganalmath SK; Barta J; Takeda N; Kumamoto H; Dhalla NS
    Can J Physiol Pharmacol; 2008 Apr; 86(4):180-9. PubMed ID: 18418427
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Single high-dose intramyocardial administration of erythropoietin promotes early intracardiac proliferation, proves safety and restores cardiac performance after myocardial infarction in rats.
    Gäbel R; Klopsch C; Furlani D; Yerebakan C; Li W; Ugurlucan M; Ma N; Steinhoff G
    Interact Cardiovasc Thorac Surg; 2009 Jul; 9(1):20-5; discussion 25. PubMed ID: 19380336
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Left ventricular remodeling after infarction: sequential MR imaging with oral nicorandil therapy in rat model.
    Saeed M; Watzinger N; Krombach GA; Lund GK; Wendland MF; Chujo M; Higgins CB
    Radiology; 2002 Sep; 224(3):830-7. PubMed ID: 12202722
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Swimming exercise training prior to acute myocardial infarction attenuates left ventricular remodeling and improves left ventricular function in rats.
    Dayan A; Feinberg MS; Holbova R; Deshet N; Scheinowitz M
    Ann Clin Lab Sci; 2005; 35(1):73-8. PubMed ID: 15830712
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Effects of pravastatin, fosinopril and their combination on myocardium TNF-alpha expression and ventricular remodeling after myocardial infarction in rats].
    Wei M; Gu SM; Zhang YY; Wu YH; Wu ZG
    Zhonghua Xin Xue Guan Bing Za Zhi; 2005 May; 33(5):444-7. PubMed ID: 15932706
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Activation of IK1 channel by zacopride attenuates left ventricular remodeling in rats with myocardial infarction.
    Liu CF; Liu QH; Liu EL; Zhai XW; Zhang L; Luo TE; Zhang WF; Feng QL; Cui XL; Zhao ZQ; Cao JM; Wu BW
    J Cardiovasc Pharmacol; 2014 Oct; 64(4):345-56. PubMed ID: 25286360
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Central infusion of aldosterone synthase inhibitor attenuates left ventricular dysfunction and remodelling in rats after myocardial infarction.
    Huang BS; White RA; Ahmad M; Tan J; Jeng AY; Leenen FH
    Cardiovasc Res; 2009 Feb; 81(3):574-81. PubMed ID: 18689429
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of levosimendan therapy on myocardial infarct size and left ventricular function after acute coronary occlusion.
    Tarkia M; Stark C; Haavisto M; Kentala R; Vähäsilta T; Savunen T; Strandberg M; Saunavaara V; Tolvanen T; Teräs M; Pietilä M; Nyman L; Duvall E; Saukko P; Levijoki J; Roivainen A; Saraste A; Knuuti J
    Heart; 2016 Mar; 102(6):465-71. PubMed ID: 26762238
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Long-term but not short-term p38 mitogen-activated protein kinase inhibition improves cardiac function and reduces cardiac remodeling post-myocardial infarction.
    Kompa AR; See F; Lewis DA; Adrahtas A; Cantwell DM; Wang BH; Krum H
    J Pharmacol Exp Ther; 2008 Jun; 325(3):741-50. PubMed ID: 18334667
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Chronic urocortin 2 administration improves cardiac function and ameliorates cardiac remodeling after experimental myocardial infarction.
    Ellmers LJ; Scott NJ; Cameron VA; Richards AM; Rademaker MT
    J Cardiovasc Pharmacol; 2015 Mar; 65(3):269-75. PubMed ID: 25658462
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of eplerenone on transcriptional factors and mRNA expression related to cardiac remodelling after myocardial infarction.
    Enomoto S; Yoshiyama M; Omura T; Matsumoto R; Kusuyama T; Kim S; Izumi Y; Akioka K; Iwao H; Takeuchi K; Yoshikawa J
    Heart; 2005 Dec; 91(12):1595-600. PubMed ID: 15797934
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Chronic administration of small nonerythropoietic peptide sequence of erythropoietin effectively ameliorates the progression of postmyocardial infarction-dilated cardiomyopathy.
    Ahmet I; Tae HJ; Brines M; Cerami A; Lakatta EG; Talan MI
    J Pharmacol Exp Ther; 2013 Jun; 345(3):446-56. PubMed ID: 23584743
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Post-ischemic treatment with erythropoietin or carbamylated erythropoietin reduces infarction and improves neurological outcome in a rat model of focal cerebral ischemia.
    Wang Y; Zhang ZG; Rhodes K; Renzi M; Zhang RL; Kapke A; Lu M; Pool C; Heavner G; Chopp M
    Br J Pharmacol; 2007 Aug; 151(8):1377-84. PubMed ID: 17603558
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Impairment of cardiac function and remodeling induced by myocardial infarction in rats are attenuated by the nonpeptide angiotensin-(1-7) analog AVE 0991.
    Zeng WT; Chen WY; Leng XY; Tang LL; Sun XT; Li CL; Dai G
    Cardiovasc Ther; 2012 Jun; 30(3):152-61. PubMed ID: 21167013
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Recombinant human growth hormone secreted from tissue-engineered bioartificial muscle improves left ventricular function in rat with acute myocardial infarction.
    Rong SL; Wang YJ; Wang XL; Lu YX; Chang C; Wang FZ; Liu QY; Liu XY; Gao YZ; Mi SH
    Chin Med J (Engl); 2009 Oct; 122(19):2352-9. PubMed ID: 20079139
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Incremental benefits of repeated mesenchymal stromal cell administration compared with solitary intervention after myocardial infarction.
    Richardson JD; Psaltis PJ; Frost L; Paton S; Carbone A; Bertaso AG; Nelson AJ; Wong DT; Worthley MI; Gronthos S; Zannettino AC; Worthley SG
    Cytotherapy; 2014 Apr; 16(4):460-70. PubMed ID: 24113430
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Erythropoietin induces neovascularization and improves cardiac function in rats with heart failure after myocardial infarction.
    van der Meer P; Lipsic E; Henning RH; Boddeus K; van der Velden J; Voors AA; van Veldhuisen DJ; van Gilst WH; Schoemaker RG
    J Am Coll Cardiol; 2005 Jul; 46(1):125-33. PubMed ID: 15992646
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.